Pharmacology, Toxicology and Pharmaceutical Science
Omega-3 Fatty Acid
100%
Fatty Acid
32%
End Stage Renal Disease
22%
Placebo
20%
Cohort Study
18%
Hemodialysis
17%
Docosahexaenoic Acid
17%
Heart Infarction
16%
Polyunsaturated Fatty Acid
16%
C Reactive Protein
16%
Coronary Artery Disease
16%
Linolenic Acid
15%
Acetylsalicylic Acid
13%
Ischemic Heart Disease
13%
Clopidogrel
13%
Lipoprotein
13%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
12%
Icosapentaenoic Acid
12%
Atrial Fibrillation
12%
Cardiovascular Disease
12%
Sudden Cardiac Death
11%
Brain Ischemia
11%
Chronic Kidney Failure
11%
Phospholipid
10%
Normal Human
9%
Heart Ventricle Arrhythmia
9%
Atorvastatin
8%
Malignant Neoplasm
8%
Arachidonic Acid
8%
Atherosclerosis
7%
Coronary Artery Atherosclerosis
6%
Cell Adhesion Molecule
6%
Adiponectin
6%
Antiarrhythmic Agent
5%
Triacylglycerol
5%
Angina Pectoris
5%
Biochemistry, Genetics and Molecular Biology
Cohort Study
28%
Polyunsaturated Fatty Acid
20%
Allele
10%
Atrial Fibrillation
10%
Saturated Fatty Acid
9%
Eicosapentaenoic Acid
8%
Linoleic Acid
7%
Alpha-Linolenic Acid
6%
Clopidogrel
6%
Monounsaturated Fat
6%
Gas Chromatography
5%
Prospective Study
5%
Arachidonic Acid
5%
Medicine and Dentistry
Patient Registry
10%
Acetylsalicylic Acid
7%
Atrial Fibrillation
6%
Atrial Flutter
6%
Personalized Medicine
6%
Inflammatory Disorder
6%
Prognostic Factor
6%
Clopidogrel
6%
Heart Rate Variability
6%
Ulcerative Colitis
5%
Thrombocyte Function
5%